Carcinomatosis Of Peritoneal Cavity clinical trials

Explore recruiting carcinomatosis of peritoneal cavity clinical trials.

Recruiting carcinomatosis of peritoneal cavity studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Carcinomatosis Of Peritoneal Cavity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, randomised, open label, multicentre study of an intraperitoneal α-emitting radionuclide therapy (Radspherin®) in patients with primary advanced high-grade serous or high-grade endometrioid epithelial ovarian, fallopian tube, or primary peritoneal cancer, with peritoneal metastasis that are homologous recombination proficient and scheduled to undergo neoadjuvant chemotherapy and interval debulking surgery

Belgium, Norway, Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, randomised, open label, multicentre study to evaluate efficacy and safety of an intraperitoneal α-emitting radionuclide therapy (Radspherin®) in patients with peritoneal carcinomatosis from colorectal carcinoma following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

Netherlands, Norway, Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Carcinomatosis Of Peritoneal Cavity trials by city

Carcinomatosis Of Peritoneal Cavity in Toronto Carcinomatosis Of Peritoneal Cavity in Vancouver Carcinomatosis Of Peritoneal Cavity in Montreal Carcinomatosis Of Peritoneal Cavity in Calgary Carcinomatosis Of Peritoneal Cavity in Edmonton Carcinomatosis Of Peritoneal Cavity in Ottawa Carcinomatosis Of Peritoneal Cavity in Winnipeg Carcinomatosis Of Peritoneal Cavity in Quebec City Carcinomatosis Of Peritoneal Cavity in Hamilton Carcinomatosis Of Peritoneal Cavity in Kitchener Carcinomatosis Of Peritoneal Cavity in London Carcinomatosis Of Peritoneal Cavity in Halifax Carcinomatosis Of Peritoneal Cavity in New York Carcinomatosis Of Peritoneal Cavity in Los Angeles Carcinomatosis Of Peritoneal Cavity in Chicago Carcinomatosis Of Peritoneal Cavity in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease